42nd week of 2013 patent applcation highlights part 55 |
Patent application number | Title | Published |
20130274480 | MONOCYCLIC CYANOENONES AND METHODS OF USE THEREOF - The present invention features monocyclic cyanoenone compositions and methods for using the same in the treatment of diseases such as cancer, inflammatory diseases and neurodegenerative diseases. | 2013-10-17 |
20130274481 | PROCESS FOR THE PREPARATION OF 3-HALOALKYLPYRAZOLES - The present invention provides a process for the preparation of a compound of formula (I) wherein R | 2013-10-17 |
20130274482 | HIGHLY Z-SELECTIVE OLEFINS METATHESIS - The present invention relates generally to catalysts and processes for the Z-selective formation of internal olefin(s) from terminal olefin(s) via homo-metathesis reactions. | 2013-10-17 |
20130274483 | ASYMMETRIC SYNTHESES FOR SPIRO-OXINDOLE COMPOUNDS USEFUL AS THERAPEUTIC AGENTS - This invention is directed to asymmetric syntheses of certain spiro-oxindole derivatives, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. | 2013-10-17 |
20130274484 | AROMATIC COMPOUNDS BEARING AT LEAST ONE PHOSPHONATE OR PHOSPHINATE GROUP, PREPARATION METHOD AND USES THEREOF - An aromatic compound bearing at least a phosphonate or phosphinate group on the aromatic ring is described. Further described, is the process by which the aromatic compound is prepared, reacted with a reagent of formula (I) or (II) constituted of a diene backbone and bearing a phosphonate or phosphinate group on one of the double bonds, in the presence of a Lewis acid. | 2013-10-17 |
20130274485 | METHOD OF MANUFACTURING CYCLIC CARBONATE BY USING IONIC LIQUID POLYMER - A method of manufacturing cyclic carbonate comprises a step of “preparation,” by preparing an ionic liquid polymer; and a step of “cyclization,” by feeding carbon dioxide and epoxide into a reactor containing the ionic liquid polymer to conduct a cyclization of the carbon dioxide and the epoxide in a batch or continuous reaction manner under the catalysis of the ionic liquid polymer, and finally to produce cyclic carbonate. | 2013-10-17 |
20130274486 | PROCESS FOR THE PREPARATION OF NEBIVOLOL - The present invention relates to a novel process for the synthesis of Nebivolol product represented in Scheme (1), comprised of a reduced number of high-yield steps, and characterized by the kinetic resolution of the two epoxide pairs diastereoisomeric therebetween (mixture 1), allowing to avoid complex chromatographic separations. | 2013-10-17 |
20130274487 | HYDROGENATION OF ESTERS OR CARBONYL GROUPS WITH TETRADENTATE AMINO/IMINO-THIOETHER BASED RUTHENIUM COMPLEXES - The present invention relates to the field of catalytic hydrogenation and, more particularly, to the use of specific ruthenium catalysts, or pre-catalysts, in hydrogenation processes for the reduction of ketones and/or aldehydes into the corresponding alcohol respectively. Said catalysts are ruthenium complexes comprising a tetradentate ligand (L4) coordinating the ruthenium with: two nitrogen atoms, each in the form of a primary or secondary amine (i.e. a NH | 2013-10-17 |
20130274488 | PROCESS FOR PREPARING AN EPOXIDE - A mixture of compounds containing 1,3-dichloropropan-2-ol, 2,3-dichloropropan-1-ol, and a halogenated ketone, where the halogenated ketone content of the mixture is at least 0.0001% by weight and less than or equal to 0.1% by weight relative to the 1,3-dichloropropan-2-ol and 2,3-dichloropropan-1-ol. | 2013-10-17 |
20130274489 | METHOD FOR OBTAINING PHYTOSTEROLS AND/OR TOCOPHEROLS FROM RESIDUE OF A DISTILLATION OF THE ESTERS OF VEGETABLE OILS, PREFERABLY FROM DISTILLATION RESIDUE FROM A TRANSESTERIFICATION OF VEGETABLE OILS - The invention relates to a method for obtaining and purifying phytosterols and/or tocopherols from distillation residue from a transesterification of vegetable oils, in particular from the vegetable oil-based fatty acid methyl ester production for the field of use of biodiesel (FAME), comprising a first transesterification stage for converting partial glycerides contained in the distillation residue; separating the glycerin phase from a reaction mixture resulting from the first transesterification stage; a second transesterification stage for converting sterol esters contained in the reaction mixture; adding water to the reaction mixture after the second transesterification stage in order to generate a multiphase system; simultaneously or sequentially separating the phases of the multiphase system into a substantially sterol-containing phase; a substantially glycerin- and methanol-containing aqueous phase; and a tocopherol-containing methyl ester phase; and obtaining phytosterols from the sterol-containing phase; and optionally obtaining tocopherols from the tocopherol-containing methyl ester phase. The invention further relates to a method for purifying a phytosterol phase and/or phytosterols. | 2013-10-17 |
20130274490 | Extraction of Lipids From Algae - Various embodiments of the present invention are directed to processes and methods for extracting lipids from a variety of algae species. An exemplary method comprises treating the algae with a mixture of at least one nonpolar solvent and at least one polar solvent heated to temperature at which the nonpolar solvent and the polar solvent are miscible. | 2013-10-17 |
20130274491 | METHOD FOR PREPARING MONO OR DIALKANOL AMIDES - Disclosed is a method involving reacting a deprotonated mono- or dialkanol amine with one or more C | 2013-10-17 |
20130274492 | POLYESTER POLYAMINE AND POLYESTER POLYQUATERNARY AMMONIUM CORROSION INHIBITORS - The present invention relates to the use of a product obtainable by the reaction of a fatty acid, or mixture of acids, having the formula R | 2013-10-17 |
20130274493 | HIGH- AND LOW-VISCOSITY ESTOLIDE BASE OILS AND LUBRICANTS - Provided herein are compounds of the formula: | 2013-10-17 |
20130274494 | POLYOL SYNTHESIS FROM FATTY ACIDS AND OILS - A method for preparing polyols from fatty acid substrates such as free fatty acids, alkyl esters of fatty acids, mono-glycerides, diglycerides, and triglycerides. The method comprises the steps of (a) epoxidizing an unsaturated fatty acid substrate and (b) hydroxylating the epoxidized fatty acid substrate with at least one diol to produce a polyol or a blend of polyols. The method may be varied to produce polyols with desired functionality, molecular weights, or viscosity. | 2013-10-17 |
20130274495 | DRY FRACTIONATION METHOD FOR OIL OR FAT - The purpose of the present invention is to provide a method, whereby, in the dry fractionation of an oil or fat, a decrease in solid-liquid | 2013-10-17 |
20130274496 | KRILL OIL AND METHOD FOR MANUFACTURING THE SAME - This invention relates to krill oil and a method for manufacturing the same. The method comprises preparing krill, adding protease to the krill and performing enzyme reaction, extracting eicosapentaenoic acid, docosahexaenoic acid, phospholipids, and astaxanthin from the krill after performing the enzyme reaction, and mixing the extracted eicosapentaenoic acid, docosahexaenoic acid, phospholipids, and astaxanthin. The protease may comprise one or more chosen from serine alkaline proteases and metallo neutral proteases. The serine alkaline proteases may comprise proteases separated from | 2013-10-17 |
20130274497 | LOW MOLECULAR WEIGHT CARBOSILANES, PRECURSORS THEREOF, AND METHODS OF PREPARATION - A series of silicon compounds are provided, which are excellent precursors to small carbosilanes, such as 1,3,5-trisilapentane, 2,4,6-trisilaheptane, tris(silylmethyl)silane and tetrakis(silylmethyl)silane. A method of preparing a carbosilane involves forming a Grignard, lithium, or metallic reagent from a halomethyltrialkoxysilane, reacting the Grignard, lithium, or metallic reagent with a dihalodihydridosilane, a trihalohydridosilane, a tetrahalosilane, a dialkoxydihydridosilane, a trialkoxyhydridosilane, or a tetraalkoxysilane to yield a carbosilane precursor, and reducing the precursor to form the carbosilane. | 2013-10-17 |
20130274498 | PREPARATION OF OLIGOMERS AND CO-OLIGOMERS OF HIGHLY FLUORINATED SULFINIC ACIDS AND SALTS THEREOF - There is provided a method for preparing oligomers and co-oligomers of highly fluorinated sulfuric acids and salts thereof. | 2013-10-17 |
20130274499 | Synthesis of 2,4-Pyrimidinediamines - Disclosed herein are methods for synthesizing 2,4-pyrimidinediamines as well as intermediates used therein. | 2013-10-17 |
20130274500 | METHOD FOR PRODUCING UNSATURATED NITRILE - A method for producing an unsaturated nitrile by subjecting propane to a vapor-phase catalytic ammoxidation reaction using a fluidized bed reactor in the presence of a composite oxide catalyst containing Mo, V, and Nb, the method comprising the step of:
| 2013-10-17 |
20130274501 | PROCESS FOR PREPARING BICALUTAMIDE - The present invention provide processes for the preparation of N-[4-Cyano-3-(trifluoro methyl)phenyl]-3-[(4-fluorophenyl)sulphonyl]-2-hydroxy-2-methyl propanamide (I). | 2013-10-17 |
20130274502 | Processes For Preparing A Polymeric Compound - The present invention provides methods for preparing a polymeric compound of Formula I: | 2013-10-17 |
20130274503 | PROCESS FOR THE MANUFACTURE OF BRIDGED MONOBACTAM INTERMEDIATES - C1-C6Alkyloxy- or benzyloxy-carbonyl esters of -{3-[(E)-(1-phenyl or naphthyl C1-C4alkyl)-imino]-propyl}-amino)-acetic acid, which are intermediates for producing known bridged monobactam compounds useful in the treatment of bacterial infections. | 2013-10-17 |
20130274504 | Novel Low Molecular Weight Cationic Lipids For Oligonucleotide Delivery - The instant invention provides for novel cationic lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with oligonucleotides. It is an object of the instant invention to provide a cationic lipid scaffold that demonstrates enhanced efficacy along with lower liver toxicity as a result of lower lipid levels in the liver. The present invention employs low molecular weight cationic lipids comprising at least one short lipid chain to enhance the efficiency and tolerability of in vivo delivery of siRNA. | 2013-10-17 |
20130274505 | PROCESS FOR PRODUCING A LACTIC ESTER FROM A FERMENTATION LIQUOR CONTAINING AMMONIUM LACTATE - The present invention relates to an industrial process for producing a lactic ester containing in total at least seven carbon atoms, from a fermentation liquor containing ammonium lactate in order to avoid the inherent production of gypsum, with a high yield and according to which the loss of lactic ester in the form of lactamide is limited as much as possible. | 2013-10-17 |
20130274506 | BIOBASED CARBODIIMIDES, A PROCESS FOR PREPARATION THEREOF AND USE THEREOF - The present invention relates to novel biobased carbodiimides, a process for production thereof and use thereof. The biobased carbodiimides according to the invention comprise the reaction product of at least one carbodiimide and a carbon acid compound isolated or produced from renewable raw materials and having a functionality >1 and/or a hydroxy carboxylic ester having 2-24 carbon atoms. | 2013-10-17 |
20130274507 | PROCESS SIMPLIFICATION FOR PRECURSOR COMPOUND - The invention relates to a process for preparation of radiopharmaceutical precursors, and in particular protected amino acid derivatives which are used as precursors for production of radiolabelled amino acids for use in in vivo imaging procedures such as positron emission tomography (PET). Particularly, the invention relates to a process for preparation of a precursor useful in the preparation of the [ | 2013-10-17 |
20130274508 | SHELL AND TUBE OXIDATION REACTOR WITH IMPROVED RESISTANCE TO FOULING - The present disclosure relates to a single shell open interstage reactor (“SSOI”). The SSOI comprises a first reaction stage, an interstage heat exchanger, an open interstage region, and a second reaction stage. The SSOI may be configured for upflow or downflow operation. Further, the open interstage region of the SSOI may comprise a supplemental oxidant feed. When the open interstage region comprises a supplemental oxidant feed, the SSOI may further comprise a supplemental oxidant mixing assembly. Processes for producing acrylic acid through the oxidation of propylene are also disclosed. | 2013-10-17 |
20130274509 | Reactor and Process for Propane Oxidation - The amount of propionic acid produced in the process of oxidizing propane to acrylic acid is reduced by using a reactor with a length/diameter ratio >10 and/or maintaining the difference between the target reaction temperature and the peak temperature within the reactor to less than 20° C. | 2013-10-17 |
20130274510 | SYNTHESIS OF POLYHYDROXYALKANOATES (PHA) WITH THIOESTER GROUPS IN THE SIDE CHAIN - The present invention relates to a process for the synthesis of polyhydroxyalkanoates (PHAs) and PHAs obtained by the said process and the use of the said PHAs. The PHAs of the present invention, called PHACOS, have a novel monomeric composition, as they contain monomers with thioester groups in the side chain that confer new physicochemical properties and allow subsequent chemical modification. | 2013-10-17 |
20130274511 | Guerbet Alcohols and Methods for Preparing and Using Same - The invention relates to Guerbet alcohol precursors and Guerbet alcohols, as well as to processes for synthesizing them. | 2013-10-17 |
20130274512 | Catalysts Conversion Of Hydroxypropionic Acid Or Its Derivatives To Acrylic Acid Or Its Derivatives - Methods for catalytically dehydrating hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof to acrylic acid, acrylic acid derivatives, or mixtures thereof with high yield and selectivity and without significant conversion to undesired side products, such as, acetaldehyde, propionic acid, and acetic acid, are provided. The catalysts are mixed condensed phosphates. | 2013-10-17 |
20130274513 | Process For Production Of Acrylic Acid Or Its Derivatives From Hydroxypropionic Acid Or Its Derivatives - Processes for the catalytic dehydration of hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof to acrylic acid, acrylic acid derivatives, or mixtures thereof with high yield and selectivity and without significant conversion to undesired side products, such as, acetaldehyde, propanoic acid, and acetic acid, are provided. | 2013-10-17 |
20130274514 | Catalytic Conversion Of Lactic Acid To Acrylic Acid - Disclosed herein is the catalytic dehydration of lactic acid to acrylic acid, which is characterized by a high conversion of lactic acid, a high selectivity for acrylic acid, a high yield of acrylic acid, and correspondingly low selectivity and molar yields for undesired by-products. This is achieved with a particular class of catalysts defined by a mixture of metal-containing phosphate salts that together provide the catalyst with a very high basicity density and low acidity density. Further, the catalyst is believed to be stable and active for lengthy periods heretofore unseen in the art for such dehydration processes. | 2013-10-17 |
20130274515 | Process For Production Of Acrylic Acid Or Its Derivatives - Processes for the catalytic dehydration of hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof to acrylic acid, acrylic acid derivatives, or mixtures thereof with high yield and selectivity and without significant conversion to undesired side products, such as, acetaldehyde, propanoic acid, and acetic acid, are provided. | 2013-10-17 |
20130274516 | Method For The Production Of Acrylic Acid Or Its Derivatives - Methods for catalytically dehydrating hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof to acrylic acid, acrylic acid derivatives, or mixtures thereof with high yield and selectivity and without significant conversion to undesired side products, such as, acetaldehyde, propionic acid, and acetic acid, are provided. The catalysts are mixed monophosphates. | 2013-10-17 |
20130274517 | Process For Production Of Acrylic Acid Or Its Derivatives - Processes for the catalytic dehydration of hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof to acrylic acid, acrylic acid derivatives, or mixtures thereof with high yield and selectivity and without significant conversion to undesired side products, such as, acetaldehyde, propanoic acid, and acetic acid, are provided. The processes can be carried out either in a gas phase or in a liquid phase. | 2013-10-17 |
20130274518 | Purification Of Bio Based Acrylic Acid To Crude And Glacial Acrylic Acid - Processes for the purification of bio-based acrylic acid to crude and glacial acrylic acid are provided. The bio-based acrylic acid is produced from hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof. The purification includes some or all of the following processes: extraction, drying, distillation, and melt crystallization. The produced glacial or crude acrylic acid contains hydroxypropionic, hydroxypropionic acid derivatives, or mixtures thereof as an impurity. | 2013-10-17 |
20130274519 | THERMAL SEPARATION PROCESS - A thermal separation process between a gas ascending in a separating column and a liquid descending in the separating column, which comprise (meth)acrylic monomers, wherein the separating column comprises a sequence of crossflow mass transfer trays, the crossflow mass transfer trays of which have passage orifices for the ascending gas in crossflow direction both in front of and beyond a downcomer for the descending liquid, and such crossflow mass transfer trays and one such crossflow mass transfer tray in a sequence of crossflow mass transfer trays present in a separating column. | 2013-10-17 |
20130274520 | Purification Of Bio Based Acrylic Acid To Crude And Glacial Acrylic Acid - Processes for the purification of bio-based acrylic acid to crude and glacial acrylic acid are provided. The bio-based acrylic acid is produced from hydroxypropionic acid, hydroxypropionic acid derivatives, or mixtures thereof. The purification includes some or all of the following processes: extraction, drying, distillation, and melt crystallization. The produced glacial or crude acrylic acid contains hydroxypropionic, hydroxypropionic acid derivatives, or mixtures thereof as an impurity. | 2013-10-17 |
20130274521 | PROCESS FOR THE PREPARATION OF AND CRYSTALLINE FORMS OF OPTICAL ENANTIOMERS OF MODAFINIL - The invention relates to a polymorphic form of (−)-modafinil that produces a powder X-ray diffraction spectrum comprising intensity peaks corresponding to interplanar spacings of about 14.14, 10.66, 7.80 and 4.02 Å, and a process for the preparation thereof. | 2013-10-17 |
20130274522 | PROCESSES FOR SEPARATING ONE OR MORE AMINE BYPRODUCTS FROM ONE OR MORE DESIRED AMINES - The present invention relates to separating one or more amine byproducts from one or more desired amines. More particularly, the invention involves forming a byproduct component with one or more amine byproducts and a first adjuvant component. The byproduct component has an enhanced separation characteristic relative to separating the amine byproducts from the desired amines in the absence of an adjuvant. Preferably, the byproduct component is separated in the presence of a second adjuvant component that preferably has a boiling point less than the boiling point of the first adjuvant component. | 2013-10-17 |
20130274523 | LOW MOLECULAR WEIGHT CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY - The instant invention provides for novel cationic lipids that can be used in combination with other lipid components such as cholesterol and PEG-lipids to form lipid nanoparticles with oligonucleotides. It is an object of the instant invention to provide a cationic lipid scaffold that demonstrates enhanced efficacy along with lower liver toxicity as a result of lower lipid levels in the liver. The present invention employs low molecular weight cationic lipids with one short lipid chain to enhance the efficiency and tolerability of in vivo delivery of siRNA. | 2013-10-17 |
20130274524 | Oxidation of Alkylaromatic Compounds - In a process for oxidizing an alkylaromatic compound to the corresponding hydroperoxide, a feed comprising an alkylaromatic compound is contacted with an oxygen-containing gas in the presence of a catalyst comprising a cyclic imide. The contacting is conducted at a temperature of about 90° C. to about 150° C., with the cyclic imide being present in an amount between about 0.05 wt % and about 5 wt % of the alkylaromatic compound in the feed and the catalyst being substantially free of alkali metal compounds. The contacting oxidizes at least part of the alkylaromatic compound in said feed to the corresponding hydroperoxide. | 2013-10-17 |
20130274525 | METHOD OF SUPPLEMENTING THE CATALYST IN CONTINUOUS HYDROFORMYLATION - The present invention relates to a method of supplementing the catalyst in continuous hydroformylation during ongoing operation. | 2013-10-17 |
20130274526 | PROCESS FOR PREPARING POLYETHER POLYOLS - The present invention relates to a process for preparing polyetherols by catalytic ring-opening polymerization, wherein at least one nitrogen-containing cyclic precatalyst compound is used. | 2013-10-17 |
20130274527 | Method For The Dissolving And Rapid Hydrolyzing Of Lignocellulose Biomass, Device Thereof And Use Of the Same - A method for the dissolving and rapid hydrolyzing of the lignocellulose biomass and the device thereof are disclosed. The lignocellulose biomass is put in the pure water and rapidly heated to 330˜403° C., and then 89˜99% of the lignocellulose biomass is dissolved and rapidly hydrolyzed to saccharide in 3.38˜21.79 s. The following hydrolysis reaction can be carried out under the homogeneous phase condition for the dissolving of the lignocellulose biomass. At the same time, the solvated biomass could be easily used in the high pressure flow reactor to continuously pretreat the biomass and hydrolyze for producing saccharide, other biofuel and product. The present invention doesn't need any catalyst and doesn't pollute the environment, furthermore the process is simple and the cost is low, and it belongs to green, continuable industry encouraged by the state, and a good prospect of market application could be taken on. | 2013-10-17 |
20130274528 | Process for Preparing R-1234yf By Base Mediated Dehydrohalogenation - The invention relates to a process for preparing 2,3,3,3-tetrafluoropropene (CF | 2013-10-17 |
20130274529 | METATHESIS TRANSFORMATIONS OF MICROBIALLY-PRODUCED FATTY ACIDS AND FATTY ACID DERIVATIVES - Methods of producing olefins, bifunctional molecules, and 7-tetradecene are provided. In some embodiments, the methods comprise subjecting a omega-7-olefinic fatty acid or derivative thereof to metathesis transformation, wherein the omega-7-olefinic fatty acid or derivative thereof was produced in a genetically engineered microorganism. | 2013-10-17 |
20130274530 | METHODS AND SYSTEMS FOR OBTAINING LONG CHAIN CARBONS FROM PETROLEUM BASED OIL - Methods and system for obtaining long chain carbons that generally include forming a conversion mixture of an alcohol and a base, adding the conversion mixture to oil (such as petroleum based oil, crude oil, used oil, used motor oil, and new motor oil) to form a reaction mixture, adding a high nitrate compound the reaction mixture, and separating out the long chain carbons for use as an input by other processing such as pharmaceutical and/or additional petro-chemical processing. Additional cooling and/or filtering processes may be utilized to complete and/or optimize oil conversion. | 2013-10-17 |
20130274531 | CONVECTION ZONE OF A CRACKING FURNACE - The invention relates to a process for cracking a hydrocarbon-containing feed in a cracking furnace. A plurality of heat exchangers are arranged in the convection zone of the cracking furnace to utilize the heat of flue gas formed in the radiation zone by combustion. Depending on the type and state of matter of the hydrocarbon-containing feed, flow occurs through the heat exchangers to achieve, independently of the type and state of matter of the hydrocarbon-containing feed, an exit temperature of the flue gas in the range from 80° C. to 150° C. | 2013-10-17 |
20130274532 | Liquid Phase Isomerization Process - Liquid phase isomerization technology is employed in a manner to increase efficiency and reduce energy in paraxylene recovery. | 2013-10-17 |
20130274533 | PROCESS TO REMOVE DISSOLVED AlCl3 FROM IONIC LIQUID - Disclosed herein are processes in which precipitation permits removal of metal halides (e.g. AlCl | 2013-10-17 |
20130274534 | PARAFFIN DISPROPORTIONATION WITH ZEOLITE Y - Methods relate to disproportionation of hydrocarbons utilizing a zeolite catalyst. The methods include reacting pentanes in contact with ultrastable zeolite Y having a silica to alumina ratio of less than 80 to disproportionate the pentanes into butanes and hexanes. The ultrastable zeolite Y is defined by having a sodium oxide content of less than 1% by weight. | 2013-10-17 |
20130274535 | PROCESS FOR TERMICAL DEGRADATION OF PVC AND OTHER WASTES CONTAINING HALOGEN-CONTAINING POLYMER WASTE - The subject matter of the patent is a process technology concerning thermal degradation of plastic wastes containing PVC and other plastic waste with halogen content. The patent is characterised by grinding of the plastic waste to be treated, leading it into a dehalogenisation reactor with heavy oil fraction added forming a 1:0.3-0.8 mass ratio plastic grinding: heavy oil mixture, warming the reaction compound up to a temperature of 210-2500 C, an acidic solution is formed from the hydrogen halogen gas liberated from the substance with the known method, it is removed, while the mixture retained in the reactor chamber is forwarded to the de-polymerisation reactor, where temperature is raised to at least 4800 C, but kept below 6000 C, the hydrocarbon gas mixture generated is extracted, separated into fractions, condensed, and the ratio of the heavy oil fraction referred to above as necessary for the processing of the waste is returned to the dehalogenisation reactor to form a mixture of plastic chippings and heavy oil. | 2013-10-17 |
20130274536 | PARTICLE BEAM IRRADIATION APPARATUS AND PARTICLE BEAM THERAPY SYSTEM - When IMRT technology for a radiation therapy system utilizing an X-ray or the like is applied to a particle beam therapy system having a conventional wobbler system, it is required to utilize two or more boluses. The present invention solves the problem of excess irradiation in IMRT by a particle beam therapy system. More specifically, the problem of excess irradiation in IMRT by a particle beam therapy system is solved by raising the irradiation flexibility in the depth direction, without utilizing a bolus. A particle beam irradiation apparatus has a scanning irradiation system that performs scanning with a charged particle beam accelerated by an accelerator and is mounted in a rotating gantry for rotating the irradiation direction of the charged particle beam. The particle beam irradiation apparatus comprises a columnar-irradiation-field generation apparatus that generates a columnar irradiation field by enlarging the Bragg peak of the charged particle beam. | 2013-10-17 |
20130274537 | APPARATUS AND METHOD FOR EVALUATING A RADIATION THERAPY PLAN - The present invention relates to an apparatus and method for evaluating the safety of RTP data. According to an embodiment of the present invention, the computer-implemented method for evaluating safety of RTP data comprises the steps of: receiving first RTP data about a first concerned area of a patient; receiving a second concerned area of the patient from a user; and calculating an amount of radiation for the second concerned area by using the first RTP data and a medical image of the patient. The evaluating method of the present invention may further comprise a step of evaluating the safety of the first RTP data by using information on the amount of radiation for the second concerned area. | 2013-10-17 |
20130274538 | PARTICLE BEAM IRRADIATION APPARATUS AND PARTICLE BEAM THERAPY SYSTEM - The particle beam irradiation apparatus comprises: a position monitor that detects a passing position of a charged particle beam; and an irradiation control apparatus that calculates a distance from a predetermined reference point to the position monitor, calculates a beam irradiation position on an irradiation subject, and controls irradiation of the beam; wherein the irradiation control apparatus includes a position calculation apparatus that calculates the beam irradiation position, based on a beam position detected by the position monitor, a scanning starting point distance information on a distance from a irradiation plane of the irradiation subject to a scanning starting point, of the beam, in a scanning electromagnet, and a position monitor distance information on a distance, from the irradiation plane to the position monitor, that is calculated based on the calculated distance. | 2013-10-17 |
20130274539 | RADIATION THERAPY DEVICE CONTROLLER, PROCESSING METHOD AND PROGRAM FOR SAME - This radiation therapy device controller selects, for a plurality of body motion phases, computed tomography image data obtained which shows a diseased portion, and generates, for each rotation angles of a ray source and a sensor array, a reconstructed image. The control device generates a radiation projection image which shows the diseased portion when the radiation is radiated if the rotation angle is a predetermined rotation angle, compares the reconstructed image of each of the plurality of body motion phases with the radiation projection image, and determines a body motion phase indicated by a reconstructed image in which a difference is small, to be a current respiratory phase. As a result, a position of the diseased portion calculated for the computed tomography image data in the computed tomography image data group of the respiratory phase in advance is identified to be a current position of the diseased portion. | 2013-10-17 |
20130274540 | APPARATUS AND METHOD FOR ELECTROMAGNETIC TREATMENT - Described herein are electromagnetic treatment devices for treatment of tissue. In particular, described herein are lightweight, wearable, low-energy variations that are specifically configured to specifically and sufficiently apply energy within a specific bandpass of frequencies of a target biological pathway, such as the binding of Calcium to Calmodulin, and thereby regulate the pathway. Methods and systems for treating biological tissue are also described. | 2013-10-17 |
20130274541 | MAGNETIC CONTROL OF EYELID POSITION - Methods, devices, and kits comprising a magnetic system for automation of blinking, or to provide temporary or permanent assistance with opening or closure of the eyelids to treat disorders of the eyelids, including lagophthalmos and ptosis. | 2013-10-17 |
20130274542 | MEDICAL DEVICE FOR TREATMENT OF HUMAN PARASITISM AND OF RELATED DISEASES - The use of a magnetic field for eliminating the malaria parasite is disclosed. Furthermore, herein described is an electromedical device for the treatment of human parasitosis, and especially the malaria parasite, comprising a plurality of coils ( | 2013-10-17 |
20130274543 | INFANT INCUBATOR - An infant incubator including: a left-side treatment door, a right-side treatment door, and an end-side treatment door which are rotatably held, and door-locking devices which fixes the left-side and right-side treatment doors on the end-side treatment door; the door-locking devices are formed from: open-close knobs each mounted rotatably on the left-side and right-side treatment doors and each having a hook-shaped distal end, and knob brackets each mounted on side of the end-side treatment doors having a hollow-shape, the infant incubator in which the treatment doors are fixed in a stand state by inserting the open-close knob into the knob bracket. | 2013-10-17 |
20130274544 | INCUBATOR ASSEMBLY - An improved incubator assembly includes a number of movable walls and a circulation system having a fluid guide apparatus adjacent each movable wall. The fluid guide apparatuses generate a first jet of air in a direction generally parallel with a wall in the closed position and a second jet of air in a direction oblique to the wall in the closed position. Whenever one of the movable walls is moved from its closed position to its open position, the jet of air that had been flowing parallel with such wall continues to flow and forms an air curtain. | 2013-10-17 |
20130274546 | HYDRAULIC URETHRAL OCCLUSIVE DEVICE - A totally implantable method for occluding the urethra or bladder neck utilizing an occlusive cuff connected to a control mechanism via a conduit tube. The occlusive cuff is reversibly changed from an activated (occlusive condition) to a de-activated (non-occlusive) condition by depressing a deactivation button contained within a resilient, elastomeric sheath surrounding the control mechanism. The occlusive condition is once again obtained by depressing an activation button also situated within the resilient sheath. In the occlusive condition, a preset tension is applied to a flexible diaphragm through a tensioning suture by a constant force spring contained within the control mechanism. This tension is translated into an occlusive pressure applied to the urethra or bladder neck sufficient to prevent urinary leakage. | 2013-10-17 |
20130274547 | Tissue Stabilizing Device and Methods Including a Self-Expandable Head-Link Assembly - A tissue stabilizer including an elongated arm, a collet, and a head-link assembly. The collet is disposed at a distal end of the arm. The head-link assembly includes a tube and a spreading mechanism. The tube forms an intermediate section and opposing arms each terminating at a tip. The spreading mechanism can adjust a lateral distance between the tips, and includes first and second articulating members each having a leg and a collet interface body. The first member further includes a female hinge feature, whereas the second member includes a male hinge feature differing from the female hinge feature. The legs of are mounted to discrete regions of the tube, and the male hinge feature is pivotably coupled to the female hinge feature. Automatic spreading of a lateral distance between the tips occurs in response to a compressive force applied to the collet interface bodies. | 2013-10-17 |
20130274548 | INVASIVE INSTRUMENT FOR TREATING VESSELS - An invasive instrument for treating a vessel, which possibly includes secondary vessels, has a tip formed for the dissection of tissue at the distal end of a shaft to be introduced into the body, with at least one functional unit. The tip includes vessel receptacle means, arranged and formed such that, in the operating condition of the instrument, the functional unit of the shaft is kept clear, so that working on the vessel, a secondary vessel and/or on the surrounding tissue is possible using or by means of the functional unit and with the vessel receiving means the vessel can be fixed in a spatial position. The tip is movable relative to the shaft by means of a guide element and the tip is shiftable in axial direction, so that during the procedure a vessel arranged in the vessel receiving means can be spaced selectively from the functional unit. | 2013-10-17 |
20130274549 | ENDOSCOPES ENHANCED WITH PATHOGENIC TREATMENT - Various endoscopes are integrated with an applicator configured for delivering a therapeutic solution to an internal anatomic target that may be infected by pathogenic microorganisms and a UV light-emitting device transmitting UV light thereto. | 2013-10-17 |
20130274550 | ENDOSCOPE - An endoscope includes a tube having a single layer structure or a laminated structure made up of a plurality of layers, a branching member that branches a tubular path in an endoscope operation section and has a tube connection section to which the tube is connected, a channel locking member that sandwiches the tube with the tube connection section to thereby fix the tube to the branching member in close contact, and a fastening member that presses and brings into close contact the tube sandwiched between the tube connection section and the channel locking member, in which the channel locking member is formed so as to have a tapered portion that covers an outer circumference of the tube and have at least one flat surface on an outer circumferential face of the tapered portion. | 2013-10-17 |
20130274551 | Fluid Channeling Component of a Multi-Camera Endoscope - There is provided herein a tip section of a multi-camera endoscope, the tip section comprising: a fluid channeling component for a tip section of a multi-camera endoscope, the fluid channeling component comprising one or more fluid channels configured for flowing for insufflation and/or irrigation fluid, and one or more support elements adapted to receive, support and/or secure a flexible electronic circuit board and/or one or more of a front camera, a side camera, an optical assembly, and a light source attached thereto; and a folded flexible electronic circuit board. | 2013-10-17 |
20130274552 | ANTENNA UNIT AND RECEIVING APPARATUS FOR CAPSULE MEDICAL APPARATUS - An antenna unit includes a receiving antenna which receives in-vivo information of a subject transmitted from a capsule medical apparatus, a wireless-signal generator which receives the in-vivo information of the subject received by the receiving antenna and generates a wireless signal including the received in-vivo information, a power supply unit which supplies power for the wireless signal generator, an outer covering on which the receiving antenna, the wireless-signal generator, the transmitting antenna, and the power supply unit are mounted. The power supply unit is flexible and can be transformed easily according to transformation of the outer covering. | 2013-10-17 |
20130274553 | MULTI-LUMEN-CATHETER RETRACTOR SYSTEM FOR A MINIMALLY-INVASIVE, OPERATIVE GASTROINTESTINAL TREATMENT - Improved methods and devices for performing an endoscopic surgery are provided. Systems are taught for operatively treating gastrointestinal disorders endoscopically in a stable, yet dynamic operative environment, and in a minimally-invasive manner. Such systems include, for example, an endoscopic surgical suite. The surgical suite can have a reversibly-expandable retractor that expands to provide a stable, operative environment within a subject. The expansion can be asymmetric around a stabilizer subsystem to maximize space for a tool and an endoscope to each be maneuvered independently to visualize a target tissue and treat the target tissue from outside the patient in a minimally invasive manner. | 2013-10-17 |
20130274554 | ENDOSCOPE - An endoscope includes a rigid portion having an illuminating portion disposed therein and a cover integrally molded to include a transparent first resin member and a colored second resin member. The first resin member configures a first molded portion including an illumination window forming portion which includes an incident surface on which the illumination light is made incident and an emission surface from which the incident illumination light is emitted and an eaves portion projecting from the illumination window forming portion and including a first surface located on the emission surface side and a second surface located on the incident surface side. The second resin member configures a second molded portion forming a cover external shape that covers, the side surface of the illumination window forming portion, the first surface of the eaves portion, and the second surface of the eaves portion. | 2013-10-17 |
20130274555 | MEMBER FOR MEDICAL DEVICE - An object of the present invention is to provide a member for a medical device that is imparted with flexibility and has superior damage tolerance even when reduced in thickness. The present invention provides a member for a medical device molded from a material composed of multiple components, wherein at least one of the multiple components is an elastomer, and at least one of the multiple components has rebound resilience of 1% to 30%. | 2013-10-17 |
20130274556 | AIRWAY MANAGEMENT - The claimed subject matter provides systems and/or methods that facilitate improving visualization associated with intubation. A dynamically articulating laryngoscope blade can be controlled to configure to normal anatomic variants and pathologic abnormalities to facilitate placing of an endotracheal tube into a patient's trachea. Further, cameras can be integrated into and/or mounted upon the dynamically articulating laryngoscope blade. The cameras can enable stereoscopic visualization of the laryngeal aperture allowing for depth perception. Moreover, the cameras can be moved independently of the blade allowing for optimal viewing of the laryngeal opening. | 2013-10-17 |
20130274557 | DETACHABLE DILATOR BLADE - A dilator assembly includes a dilator and a retractor member that is configured to be removably attached to the dilator. | 2013-10-17 |
20130274558 | SURGICAL DEVICE FOR INTERNALLY MANIPULATING AN ORGAN - A surgical device includes a rigid shaft connected between a handle and a head. The head of the surgical device is sized for insertion into an organ such as a vagina, a uterus, a rectum, or an esophagus. The head includes an expansion plate and a door coupled to a central plate. The central plate has a distal end connected to the rigid shaft, an anterior surface, and a recess formed in a posterior side of the central plate that provides a posterior surface opposite the anterior surface. The expansion plate is coupled to and movable relative to the anterior surface of the central plate. The door is coupled disposed within the recess of the central plate and movable relative to the posterior surface of the central plate. The expansion plate is movable independently of the door to allow the head to expand and move the organ. | 2013-10-17 |
20130274559 | Foam Introduction System Including Modified Port Geometry - A surgical apparatus for positioning within a tissue tract accessing an underlying body cavity includes a seal anchor member including leading portion, a trailing portion, and an intermediate portion disposed between the leading and trailing portions. The leading portion of the seal anchor member is configured and adapted to ease insertion of the seal anchor member into the tissue tract. Subsequent to insertion of the seal anchor member, the leading portion of the seal anchor member is also configured and adapted to facilitate securing and/or anchoring of the seal anchor member within the tissue tract. | 2013-10-17 |
20130274560 | VAGINAL MANIPULATOR INCLUDING EXPANSION PLATE AND DOOR - A vaginal manipulator includes a shaft and a head. The head includes a central plate having a distal end connected to the shaft, an expansion plate coupled to and configured to move radially away from the central plate, and a door having a constrained end and a free end. The constrained end of the door is hinged to the central plate and the free end of the door is configured to move away from the central plate. When the vaginal manipulator is inserted into a vagina, the expansion plate is movable relative to the central plate to displace an anterior wall of the vagina and the door is movable relative to the central plate to displace a posterior wall of the vagina into a trans-abdominal line of sight. | 2013-10-17 |
20130274561 | VAGINAL MANIPULATOR INCLUDING LIGHT SOURCE - A vaginal manipulator includes a shaft, a handle connected to a first end of the shaft, and a head connected to a second end of the shaft. The head includes a rigid anterior surface that moves independently from a rigid posterior surface of the head. When the vaginal manipulator is inserted into a vagina, the rigid anterior surface is movable to displace an anterior wall of the vagina and the rigid posterior surface is movable to displace a posterior wall of the vagina. A light source is provided on the head. | 2013-10-17 |
20130274562 | CARDIAC CATHETER EMPLOYING CONFORMAL ELECTRONICS FOR MAPPING - An apparatus for medical diagnosis and/or treatment is provided. The apparatus includes a flexible substrate, an intermediate bus disposed on the flexible substrate, and a plurality of sensing elements disposed on the flexible substrate and coupled to the intermediate bus. The plurality of sensing elements and intermediate bus are disposed on the flexible substrate such that the sensing elements are disposed at areas of minimal strain of the flexible substrate. | 2013-10-17 |
20130274563 | APPURTENANCES TO CAVITY WOUND DRESSINGS - Appurtenances to cavity wound medical dressings are described. In some embodiments, an appurtenance to a cavity wound dressing includes: a substrate including at least one wound-facing surface, the wound-facing surface configured to be oriented facing a wound surface of a cavity wound; and a plurality of sensor units attached to the substrate, the plurality of sensor units oriented and positioned on the substrate relative to the wound surface of the cavity wound. | 2013-10-17 |
20130274564 | APPARATUS AND METHOD FOR PREDICTING UPCOMING STAGE OF CAROTID STENOSIS - An apparatus and a method predict an upcoming stage of carotid stenosis. The apparatus includes a receiving unit, a cluster determining unit, a risk factor score extracting unit, a prediction model storage unit, and a predicting unit. The method includes receiving a patient's medical test data relating to carotid stenosis; determining a cluster to which the patient's medical test data belong based on a gender of the patient; extracting from the patient's medical test data a risk factor score comprising a result of carotid stenosis ultrasonography; storing a plurality of prediction models used to predict an upcoming stage of carotid stenosis; and obtaining an outcome by applying a value indicating a stage of carotid stenosis corresponding to the result of carotid stenosis ultrasonography and the extracted risk factor score to the prediction model corresponding to the determined cluster among the plurality of prediction models. | 2013-10-17 |
20130274565 | OUTPATIENT HEALTH EMERGENCY WARNING SYSTEM - A medical system for sensing a physiological state requiring defibrillation in a patient. The system comprising: a low power sensor, a physiological parameter measuring device, and a processor. The low power sensor generating a baseline signal relating to a physiological status of said patient. The physiological parameter measuring device comprising at least one higher power sensor configured to output at least one physiological parameter signal indicative of at least one physiological parameter of said patient. The processor assessing the baseline signal and determining if the physiological status is outside predetermined threshold boundaries. | 2013-10-17 |
20130274566 | MOISTURE METER - Provided is a moisture meter that can easily measure a moisture content of a subject and can be effectively used as means for assisting the subject in appropriately regulating the moisture content. A moisture meter for measuring a moisture content of a subject includes: a moisture measuring unit that is held in an armpit of a subject so as to measure a moisture content of the subject, the moisture measuring unit including measurement current supply electrode portions and voltage measurement electrode portions that make contact with a skin surface of the armpit; and a temperature measuring unit that is held in the armpit of the subject so as to measure the temperature of the subject. | 2013-10-17 |
20130274567 | SENSOR SYSTEM FOR IMPLANTATION INTO A BODY, AND METHOD FOR PRODUCING THE SENSOR SYSTEM - The invention relates to a sensor system for implantation into a body of a living being, comprising a measuring unit for measuring parameters of the body and generating corresponding measurement signals, a transmitting unit for transmitting signals using the measurement signals, a control and analysis unit which is connected to the measuring unit and the transmitting unit in order to process and prepare the measurement signals and control the transmitting unit for transmitting the transmitting signals, an energy storing unit for supplying energy to the units, and an outer casing that at least partly surrounds the measuring unit, the transmitting unit, the analysis unit, and the energy storing unit. The system comprises at least two thinned substrate layers on which the measuring unit, the analysis unit, and the transmitting unit at least partly take the form of circuits, said substrate layers being stacked one above the other and being connected to one another by means of electric vias for the transmission of signals between the substrate layers. | 2013-10-17 |
20130274568 | FULLY INTEGRATED WEARABLE OR HANDHELD MONITOR - An arrangement comprises a housing containing one or more components configured for at least one of body fluid sampling and analysis. The arrangement includes a housing containing one or more components configured for at least one of body fluid sampling and analysis, and a body attachment element. The housing and the body attachment element are connected by a quick-release mechanism configured to facilitate removal of the housing from the body attachment element. | 2013-10-17 |
20130274569 | SYSTEM AND METHOD FOR VOICE CONTROL OF MEDICAL DEVICES - A light-based medical diagnostic system includes a plurality of semiconductor diodes with pump beams and a multiplexer capable of combining the pump beams and generating at least a multiplexed pump beam comprising one or more wavelengths. A first waveguide structure is configured to receive at least a portion of the one or more wavelengths and outputs a first optical beam. A second waveguide structure is configured to receive at least a portion of the first optical beam and to communicate at least the portion of the first optical beam to an output end of the second waveguide structure to form an output beam. A lens system is configured to receive at least a portion of the output beam and to communicate at least the portion of the output beam onto a part of a patient's body, such as a patient's blood. | 2013-10-17 |
20130274570 | APPARATUS AND METHOD FOR PREDICTION OF RAPID SYMPTOMATIC BLOOD PRESSURE DECREASE - A monitoring arrangement | 2013-10-17 |
20130274571 | HYPERSATURATION INDEX - Embodiments of the present disclosure provide a hypersaturation index for measuring a patient's absorption of oxygen in the blood stream after a patient has reached 100% oxygen saturation. This hypersaturation index provides an indication of the partial pressure of oxygen of a patient. In an embodiment of the present invention, a hypersaturation index is calculated based on the absorption ratio of two different wavelengths of energy at a measuring site. In an embodiment of the invention, a maximum hypersaturation index threshold is determined such that an alarm is triggered when the hypersaturation index reaches or exceeds the threshold. In another embodiment, an alarm is triggered when the hypersaturation index reaches or falls below its starting point when it was first calculated. | 2013-10-17 |
20130274572 | PHYSIOLOGICAL PARAMETER TRACKING SYSTEM - A physiological parameter tracking system has a reference parameter calculator configured to provide a reference parameter responsive to a physiological signal input. A physiological measurement output is a physiological parameter derived from the physiological signal input during a favorable condition and an estimate of the physiological parameter according to the reference parameter during an unfavorable condition. | 2013-10-17 |
20130274573 | Systems And Methods For Measuring Mitochondrial Capacity - In one embodiment, measuring mitochondrial capacity includes performing arterial occlusions on a patient, measuring oxygenated hemoglobin/myoglobin and deoxygenated hemoglobin/myoglobin within the patient's body during the occlusions, calculating a blood volume correction factor that accounts for a change in blood volume that occurs during the arterial occlusions, and applying the correction factor to the measured oxygenated hemoglobin/myoglobin and deoxygenated hemoglobin/myoglobin measurements to obtain correct oxygenated hemoglobin/myoglobin and deoxygenated hemoglobin/myoglobin measurements. | 2013-10-17 |
20130274574 | Electrochemical Analyte Sensor - An electrochemical analyte sensor formed using conductive traces on a substrate can be used for determining and/or monitoring a level of analyte in in vitro or in vivo analyte-containing fluids. For example, an implantable sensor may be used for the continuous or automatic monitoring of a level of an analyte, such as glucose, lactate, or oxygen, in a patient. The electrochemical analyte sensor includes a substrate and conductive material disposed on the substrate, the conductive material forming a working electrode. In some sensors, the conductive material is disposed in recessed channels formed in a surface of the sensor. An electron transfer agent and/or catalyst may be provided to facilitate the electrolysis of the analyte or of a second compound whose level depends on the level of the analyte. A potential is formed between the working electrode and a reference electrode or counter/reference electrode and the resulting current is a function of the concentration of the analyte in the body fluid. | 2013-10-17 |
20130274575 | CARBON DIOXIDE GAS MEASUREMENT SYSTEM AND METHOD - A measurement system for measuring carbon dioxide in a tissue sample is provided. The system includes a housing having a distal end and a proximal end, the distal end including a recessed area; electrodes positioned within the housing, said electrodes in mating relationship; a conductive media in contact with said electrodes; and a recognition layer disposed between said electrodes and said recessed area. | 2013-10-17 |
20130274576 | MEDICATION DELIVERY DEVICE WITH MULTI-RESERVOIR CARTRIDGE SYSTEM AND RELATED METHODS OF USE - A medication delivery system for delivering medicament to a body of a user. The medication delivery system may include a housing having a plurality of medicament reservoirs therein, a first sensor configured to continuously monitor a parameter of the body, and a pump mechanism configured to pump medicament from each of the plurality of medicament reservoirs to a delivery mechanism having a portion disposed within the body of the user. | 2013-10-17 |
20130274577 | Medication Delivery Device and Related Methods of Use - Embodiments of the disclosure relate to medical devices and, in particular, to devices for delivery of basal and/or bolus doses of one or more medicaments to a patient. In one embodiment, a medical device for delivering a medicament to the body of a user may include a reservoir configured to contain the medicament, a delivery mechanism for channeling the medicament from the reservoir to the user, a pumping mechanism for pumping the medicament from the reservoir, through the delivery mechanism, and to the user, wherein the medical device may be configured to deliver a dose of the medicament to the user. The medical device may also include a sensor for monitoring a parameter of the body and a display of information to alert and keep the user informed. | 2013-10-17 |
20130274578 | Artificial Tissue Systems and Uses Thereof - An implant system and a method for controlling the natural and artificial microenvironments surrounding an implanted device using an artificial tissue system (ATS) and includes methods of diagnostic and testing related thereto. The ATS, among other things, induce better integration, function, and extended lifespan of the devices at the site of implantation. The ATS includes cells, such as naturally occurring, engineered, and/or artificial cells; matrices such as natural, engineered, artificial and/or hybrid matrices; tissue response modifiers (TRM); and/or cell response modifiers (CRM). The specific composition of the ATS is based on the nature of the tissue in which ATS-device combination is implanted and the nature of the implant device, as well as the required function and lifespan of the implanted device. Additionally, the ATS, as well as ATS-device combinations can be utilized in vitro to aid in the design of improved ATS, devices and ATS-device combinations for in vivo uses. | 2013-10-17 |
20130274579 | ALLOWING MEASUREMENTS TO BE MADE OF A BLOOD SAMPLE - An apparatus and a method for measuring a property of a blood sample is shown. The apparatus comprises of a housing having an aperture; a shaft mounted inside the housing; a testing member rotatably mounted on the shaft; an actuating member coupled to the housing and configured to exert a force against the testing member; and a lancet for eliciting a blood sample fixedly coupled to and protruding substantially radially from the testing member and configured to co-rotate with the testing member. The apparatus is further configured such that the lancet is aligned with the aperture in the housing when the testing member is in a first position. The testing member is configured, in the presence of a force exerted against the testing member by the actuator member, to translate to a second position in which the lancet is in a skin penetrating position. | 2013-10-17 |
20130274580 | ANALYSIS OF EEG SIGNALS TO DETECT HYPOGLYCAEMIA - Apparatus for detecting hypoglycemia or impending hypoglycemia by analysis of an EEG comprises at least one EEG measuring electrode ( | 2013-10-17 |